Impact of Cantilever Design on Clinical, Radiographic, and Volumetric Parameters: a Retrospective Study
Impact of Cantilever Design in the Posterior Areas of the Mandible on Clinical, Radiographic, and Volumetric Parameters: a Retrospective Study With 8-year Follow-up
1 other identifier
observational
27
1 country
1
Brief Summary
The present retrospective study aims to evaluate the impact of cantilever design in the posterior areas of the mandible on clinical, radiographic, and volumetric parameters with an 8-year follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 25, 2023
CompletedFirst Posted
Study publicly available on registry
October 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 27, 2023
CompletedMay 9, 2024
May 1, 2024
8.9 years
July 25, 2023
May 7, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Probing Depth of the Peri-implant Pocket (PPD)
It is measured from the mucosal margin to the bottom of the probable peri-implant sulcus and expressed in mm.
8 years
Plaque Index (PI)
Evaluation of Plaque index (PI), expressed as the percentage of positive sites and measured at 4 implant sites (mesio-buccal, mesio-oral, disto-buccal and disto-oral) throught Michigan-grade periodontal probe.
8 years
Keratinized mucosa (KM)
Evaluation of Keratinized mucosa width (KM), measured from the restoration margin to the mucogingival junction and expressed in mm.
8 years
Mucosal recession (MR)
Mucosal recession (MR), of the peri-implant soft tissue, measured from the restoration margin to the mucosal margin and expressed in mm. Coronal from restoration margin is defined as (+) and apical from restoration margin defined as (-);
8 years
Bleeding and/or suppuration on probing (BOP/SUP)
Evaluation of Bleeding and/or suppuration on probing (BOP/SUP), within 30 seconds after probing and expressed as the percentage of positive sites and measured at 4 implantation sites (mesio-buccal, mesio-oral, disto-buccal and disto-oral).
8 years
Secondary Outcomes (2)
Volumetric analysis at baseline and after 8 years of follow-up
8 years
Radiographic examination at baseline and after 8 years of follow-up
8 years
Eligibility Criteria
Patients with partial edentulism, treated comprehensively and continuously between 2015 and 2023, were enrolled at the School of Dentistry of the Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy, and a private outpatient regimen.
You may qualify if:
- Patients aged ≥18 years;
- Patients with partial edentulism;
- Patients with systemic health or controlled medical conditions;
- Patients with healthy or treated periodontal conditions;
- Patients enrolled in regular supportive periodontal therapy (SPT);
- Patients without clinical signs of oral parafunctions (bruxism or clenching);
- Presence of 1 osteointegrated dental implant in posterior region (premolar or molar) of mandible, after transmucosal placement and healing at 3-6 months;
- Tissue level solid-screw implants with a sand-blasted and acid etched (SLA) surface with an endosseous diameter of 4.1 mm, a length of 8, 10 or 12 mm, a shoulder diameter of 4.8 mm and a supracrestal machined neck with a height of 1.8 mm (Straumann Dental Implant System, Institute Straumann AG); Use of prefabricated titanium abutments;
- Monolithic zirconia SCs manufactured by digital flow; Screwed SCs with a mesial or distal cantilever extension;
- Alternative crown design (ACD) with eccentric implant insertion, with crown-like-premolar and with distal or mesial cantilever with ovoid conformation. In the latter case, the lower abutment cross-section in the region between the crown-bridge connector mimics the shape of a root, creating an "interradicular" access route to facilitate oral hygiene maneuvers;
- Absence of occlusal contacts or guidance on the cantilever extension at baseline;
- Opposing dentition consisting of natural teeth or fixed or removable restorations;
- Availability of periapical radiography at baseline (i.e., loading of SCs) and at the analyzed timings (after 1, 3, 5, and 8 years);
- Availability of clinical measurements, such as pocket probing depth (PPD), plaque index (PI), bleeding index at probing (BOP), suppuration at probing (SUP), keratinized mucosa (KM), and mucosal recession (MR) taken at baseline (i.e., at loading of the SCs) and at 8 years after SCs loading, at four sites/implant with a Michigan graded periodontal probe (Deppeler SA); Availability of intraoral scans at baseline (i.e., at loading of the SCs) and at the analyzed time points (after 1, 3, 5, and 8 years after SCs loading) and executed using 3 Shape TRIOS 3, Germany GmbH.
You may not qualify if:
- Untreated or active periodontal diseases;
- Type I implant placement;
- SCs with cantilever extension replacing mandibular and maxillary incisors and canines; - - SCs with cantilever extension replacing posterior maxillary;
- SCs with cantilever extension supported by implants with a diameter ≤3.5 mm;
- SCs supported by hollow-screw and hollow-cylinder implants;
- Technical complications, such as fractures of implants, abutments, and the prosthetic artifact;
- Smoking habit (more than 15 cigarettes/day);
- Drug or alcohol abuse;
- Uncontrolled systemic diseases that could affect bone remodeling during implant osseointegration; or soft tissue healing (e.g., uncontrolled diabetes mellitus with HbA1c\>7, osteoporosis);
- Use of medications that could affect bone remodeling during implant osseointegration or soft tissue healing (e.g., steroids, antiresorptive medication, radiotherapy);
- Autoimmune and/or inflammatory diseases affecting the oral cavity;
- Neurological or psychiatric handicap that could interfere with oral hygiene;
- Pregnancy or lactation periods.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOU Policlinico G. Rodolico
Catania, 95124, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Gaetano Isola
University of Catania
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
July 25, 2023
First Posted
October 27, 2023
Study Start
January 1, 2015
Primary Completion
November 27, 2023
Study Completion
November 27, 2023
Last Updated
May 9, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share